The Priestley Medal was awarded to K. Barry Sharpless
On Mar. 31, 2019, the American Chemical Society awarded the Priestley Medal to K. Barry Sharpless “to recognize…
Biotechnology | Disease | FDA | Oncology | Therapeutics
The FDA approved new formulation of Herceptin for subcutaneous use
On Feb. 28, 2019, the U.S. Food and Drug Administration (FDA) approved trastuzumab and hyaluronidase-oysk injection,for subcutaneous use…
deCODE published the first full resolution genetic map of the human genome
On Jan. 24, 2019, scientists at deCODE genetics in Iceland, a subsidiary of Amgen, published the first genetic…
The Earth BioGenome Project was founded
On Nov. 1, 2018, the Earth BioGenome Project (EBP) was launched, a global effort to sequence the genetic…
Researchers at JCVI, UCSD, and Scripps Oceanography discovered genetic basis for how harmful algal blooms become toxic
On Sept. 27, 2018, Researchers from Scripps Institution of Oceanography at UCSD and the J. Craig Venter Institute…
UCSD researchers discovered that a type of DNA-repairing enzyme is neutralized by DNA lesions caused by exposure to ultraviolet light
On Aug. 22, 2018, University of California, San Diego (UCSD) researchers with colleagues in Spain and Finland, described…
Cancer registry managed by Keck School of Medicine of USC received $43.7 million award
On May 21, 2018, the National Cancer Institute awarded Keck School of Medicine of USC and USC Norris…
UCLA researchers characterized the mechanism of the mammalian EAK-7 gene, or mEAK-7
On May 14, 2018, University of California, Los Angeles (UCLA) researchers characterized the mechanism of the mammalian EAK-7…
$20 million gift created research center on longevity and aging at University of Southern California
On May 9, 2018, a new center dedicated to research on longevity and healthy aging was established at…
USC recruited participants for landmark $1.5 billion precision medicine research initiative
On May 1, 2018, Keck School of Medicine of USC and nationwide partners launched a landmark $1.5 billion…
Amgen announced Rhode Island as location of first US next-generation biomanufacturing plant
On Apr. 10, 2018, Amgen announced plans to build a new state-of-the-art next-generation biomanufacturing plant at its 75-acre…
USC scientists launched global effort to find the next diabetes drug
On Mar. 23, 2018, University of Southern California (USC) researchers launched a massive scientific effort to construct a…
Norris Healthcare Center opened for patient care
On Mar. 9, 2018, the Keck Medicine of University of Southern California (USC) significantly expanded its patient care…
Biotechnology | Disease | FDA | Oncology | Therapeutics
FDA approved first biosimilar for the treatment of certain breast and stomach cancers
On Dec. 1, 2017, the U.S. Food and Drug Administration (FDA) approved Mylan’s Ogivri (trastuzumab-dkst) as a biosimilar…
Disease | FDA | Therapeutics
Genentech drug Hemlibra (emicizumab-kxwh) was approved
On Nov. 16, 2017, the the U.S. Food and Drug Administration (FDA) approved the Genentech drug Hemlibra (emicizumab-kxwh)…
FDA approval brought first gene therapy to the U.S.
On Aug. 30, 2017, the U.S. Food and Drug Administration (FDA) approved Kymriah (tisagenlecleucel) for certain pediatric and…
The Scripps Research Institute and ShangPharma Innovation announced a strategic collaboration
On Jun. 8, 2017, The Scripps Research Institute (TSRI) and ShangPharma Innovation (SPII) announced a strategic collaboration to…
Genentech drug Ocrevus (ocrelizumab) was approved
On Mar. 28, 2017, Genentech drug Ocrevus (ocrelizumab) was approved by the U.S. Food and Drug Administration (FDA)…
Scripps Research Institute scientists created first stable semisynthetic organism
On Jan. 23, 2017, scientists at The Scripps Research Institute (TSRI) announced the development of the first stable…
Genomic sequencing illuminated Shigella outbreaks in California
On Dec. 23, 2016, researchers at University of California (UC) Davis and California Department of Public Health announced…
Marc and Lynne Benioff’s $20 million gift to USC supports research and treatment innovations to fight cancer
On Sept. 29, 2016, University of Southern California (USC) Trustee Marc Benioff ’86 and his wife, Lynne, gifted…
UC Berkeley, UC San Francisco and Stanford partnered in $600 million Chan Zuckerberg science ‘Biohub’
On Sept. 21, 2016, the University of California, Berkeley, UC San Francisco and Stanford University joined forces in…
Scripps Health and MD Anderson Cancer Center announced partnership to create clinically integrated cancer program
On Aug. 29, 2016, Scripps Health and MD Anderson Cancer Center announced a partnership agreement to create Scripps…
The Stanford Cancer Institute became a NCI Designated Comprehensive Cancer Center
On Jul. 5, 2016, The Stanford Cancer Institute announced it had been designated a Comprehensive Cancer Center by…
ACIP voted that live attenuated influenza vaccine (LAIV) should not be used during the 2016-2017 flu season
On Jun. 22, 2016, the U.S. Centers for Disease Control and Prevention’s (CDC) Immunization Practices Advisory Committee (ACIP)…
Artificial Intelligence | Biotechnology | Diagnostics | Environmental | Marine Science | Non-Profit Research | Therapeutics
UCSD joined the National Microbiome Initiative, an effort to better understand microbiomes and develop tools to protect and restore healthy microbiome functionﾠ
On May 13, 2016, the White House Office of Science and Technology Policy (OSTP) announced a new National…
$200 million gift launched the Lawrence J. Ellison Institute for Transformative Medicine of USC
On May 12, 2016, technology entrepreneur and founder of Oracle, Larry Ellison announced the donation $200 million to…
Biotechnology | FDA | Oncology | Therapeutics
Genentech drug Venclexta (venetoclax) was approved
On Apr. 11, 2016, the U.S. Food and Drug Administration (FDA) announced that it had granted accelerated approval…
The Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech was founded
In 2016, the Tianqiao and Chrissy Chen Institute for Neuroscience at Caltech was founded with a $1 billion…
Genentech drug Alecensa (alectinib) was approved by FDA
On Dec. 11, 2015, Genentech announced that it’s drug Alecensa (alectinib) was approved by the U.S. Food and…